Carcinogenesis Advance Access originally published online on August 27, 2004
Carcinogenesis 2004 25(12):2433-2441; doi:10.1093/carcin/bgh264
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.25 no.12 © Oxford University Press 2004; all rights reserved.
ARTICLE |
Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer
1 Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany, 2 Department of Tumor Biology, Center of Oncology-M. Sklodowska-Curie Memorial Institute, Gliwice, Poland, 3 Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany and 4 Thoraxklinik Heidelberg-Rohrbach, Heidelberg, Germany
5 To whom correspondence should be addressed Email: o.popanda{at}dkfz-heidelberg.de
Several polymorphisms in DNA repair genes have been reported to be associated with lung cancer risk including XPA (–4G/A), XPD (Lys751Gln and Asp312Asn), XRCC1 (Arg399Gln), APE1 (Asp148Glu) and XRCC3 (Thr241Met). As there is little information on the combined effects of these variants, polymorphisms were analyzed in a case-control study including 463 lung cancer cases [among them 204 adenocarcinoma and 212 squamous cell carcinoma (SCC)] and 460 tumor-free hospital controls. Odds ratios (OR) adjusted for age, gender, smoking and occupational exposure were calculated for the variants alone and combinations thereof. For homozygous individuals carrying the Glu variant of APE1, a protective effect was found (OR = 0.77, CI = 0.51–1.16). Individuals homozygous for the variants XPA (–4A) (OR = 1.53, CI = 0.94–2.5), XPD 751Gln (OR = 1.39, CI = 0.90–2.14) or XRCC3 241Met (OR = 1.29, CI = 0.85–1.98) showed a slightly higher risk for lung cancer overall. In the subgroup of adenocarcinoma cases, adjusted ORs were increased for individuals homozygous for XPA (–4A) (OR = 1.62, CI = 0.91–2.88) and XRCC3 241Met (OR = 1.65; CI = 0.99–2.75). When analyzing the combined effects of variant alleles, 54 patients and controls were identified that were homozygous for two or three of the potential risk alleles [i.e. the variants in nucleotide excision repair, XPA (–4A) and XPD 751Gln, and in homologous recombination, XRCC3-241Met]. ORs were significantly increased when all patients (OR = 2.37; CI = 1.26–4.48), patients with SCC (OR = 2.83; CI = 1.17–6.85) and with adenocarcinoma (OR = 3.05; CI = 1.49–6.23) were analyzed. Combinations of polymorphisms in genes involved in the same repair pathway (XPA + XPD or XRCC1 + APE1) affected lung cancer risk only in patients with SCC. These results indicate that lung cancer risk is only moderately increased by single DNA repair gene variants investigated but it is considerably enhanced by specific combinations of variant alleles. Analyses of additional DNA repair gene interactions in larger population-based studies are warranted for identification of high-risk subjects.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Gu, M. Wang, M. Wang, Z. Zhang, and J. Chen The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies Mutagenesis, November 1, 2009; 24(6): 507 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Gandara, T. Kawaguchi, J. Crowley, J. Moon, K. Furuse, M. Kawahara, S. Teramukai, Y. Ohe, K. Kubota, S. K. Williamson, et al. Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics J. Clin. Oncol., July 20, 2009; 27(21): 3540 - 3546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. AGACHAN, O. KUCUKHUSEYIN, P. AKSOY, A. TURNA, I. YAYLIM, U. GORMUS, A. ERGEN, U. ZEYBEK, B. DALAN, and T. ISBIR Apurinic/Apyrimidinic Endonuclease (APE1) Gene Polymorphisms and Lung Cancer Risk in Relation To Tobacco Smoking Anticancer Res, June 1, 2009; 29(6): 2417 - 2420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saviozzi, P. Ceppi, S. Novello, P. Ghio, M. Lo Iacono, P. Borasio, A. Cambieri, M. Volante, M. Papotti, R. A. Calogero, et al. Non-Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways Cancer Res., April 15, 2009; 69(8): 3390 - 3396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Lo, Y.-S. Jou, C.-F. Hsiao, G.-C. Chang, Y.-H. Tsai, W.-C. Su, K.-Y. Chen, Y.-M. Chen, M.-S. Huang, C. Y. Hu, et al. A Polymorphism in the APE1 Gene Promoter is Associated with Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 223 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, D. C. Christiani, A. Risch, O. Popanda, A. Haugen, S. Zienolddiny, S. Benhamou, C. Bouchardy, Q. Lan, M. R. Spitz, et al. International Lung Cancer Consortium: Pooled Analysis of Sequence Variants in DNA Repair and Cell Cycle Pathways Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3081 - 3089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Margulis, J. Lin, H. Yang, W. Wang, C. G. Wood, and X. Wu Genetic Susceptibility to Renal Cell Carcinoma: The Role of DNA Double-Strand Break Repair Pathway Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2366 - 2373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pandeya, G. M. Williams, S. Sadhegi, A. C. Green, P. M. Webb, and D. C. Whiteman Associations of Duration, Intensity, and Quantity of Smoking with Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus Am. J. Epidemiol., July 1, 2008; 168(1): 105 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, M. R. Spitz, H. Yang, C. Lu, D. J. Stewart, and X. Wu Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer Clin. Cancer Res., October 1, 2007; 13(19): 5974 - 5981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Michiels, P. Danoy, P. Dessen, A. Bera, T. Boulet, C. Bouchardy, M. Lathrop, A. Sarasin, and S. Benhamou Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers Carcinogenesis, August 1, 2007; 28(8): 1731 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Breton, W. Zhou, M. L. Kile, E.A. Houseman, Q. Quamruzzaman, M. Rahman, G. Mahiuddin, and D. C. Christiani Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes Carcinogenesis, July 1, 2007; 28(7): 1520 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Miller, M. R. Karagas, P. Kraft, D. J. Hunter, P. J. Catalano, S. H. Byler, and H. H. Nelson XPA, haplotypes, and risk of basal and squamous cell carcinoma Carcinogenesis, August 1, 2006; 27(8): 1670 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Popanda, X.-L. Tan, C. B. Ambrosone, S. Kropp, I. Helmbold, D. von Fournier, W. Haase, M. L. Sautter-Bihl, F. Wenz, P. Schmezer, et al. Genetic Polymorphisms in the DNA Double-Strand Break Repair Genes XRCC3, XRCC2, and NBS1 Are Not Associated with Acute Side Effects of Radiotherapy in Breast Cancer Patients. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1048 - 1050. [Full Text] [PDF]
|
|
|
|
 |
|
 R. de las Penas, M. Sanchez-Ronco, V. Alberola, M. Taron, C. Camps, R. Garcia-Carbonero, B. Massuti, C. Queralt, M. Botia, R. Garcia-Gomez, et al. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients Ann. Onc., April 1, 2006; 17(4): 668 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zienolddiny, D. Campa, H. Lind, D. Ryberg, V. Skaug, L. Stangeland, D. H. Phillips, F. Canzian, and A. Haugen Polymorphisms of DNA repair genes and risk of non-small cell lung cancer Carcinogenesis, March 1, 2006; 27(3): 560 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Heck, J. L. Argueso, Z. Gemici, R. G. Reeves, A. Bernard, C. F. Aquadro, and E. Alani Negative epistasis between natural variants of the Saccharomyces cerevisiae MLH1 and PMS1 genes results in a defect in mismatch repair PNAS, February 28, 2006; 103(9): 3256 - 3261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, J. Hall, P. Brennan, and P. Boffetta Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review Am. J. Epidemiol., November 15, 2005; 162(10): 925 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bigler, C. M. Ulrich, T. Kawashima, J. Whitton, and J. D. Potter DNA Repair Polymorphisms and Risk of Colorectal Adenomatous or Hyperplastic Polyps Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2501 - 2508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Silva, O. M. Gil, V. C. Oliveira, M. N. Cabral, A. P. Azevedo, A. Faber, I. Manita, T. C. Ferreira, E. Limbert, J. E. Pina, et al. Association of Polymorphisms in ERCC2 Gene with Non-Familial Thyroid Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2407 - 2412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Majumder, N. Sikdar, R. R. Paul, and B. Roy Increased Risk of Oral Leukoplakia and Cancer Among Mixed Tobacco Users Carrying XRCC1 Variant Haplotypes and Cancer Among Smokers Carrying Two Risk Genotypes: One on Each of Two Loci, GSTM3 and XRCC1 (Codon 280) Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2106 - 2112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hoffmann, C. Isner, J. Hogel, and G. Speit Genetic polymorphisms and the effect of cigarette smoking in the comet assay Mutagenesis, September 1, 2005; 20(5): 359 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Cortes-Funes, C. Gomez, R. Rosell, P. Valero, C. Garcia-Giron, A. Velasco, A. Izquierdo, P. Diz, C. Camps, D. Castellanos, et al. Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients Ann. Onc., July 1, 2005; 16(7): 1081 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chang-Claude, O. Popanda, X.-L. Tan, S. Kropp, I. Helmbold, D. von Fournier, W. Haase, M. L. Sautter-Bihl, F. Wenz, P. Schmezer, et al. Association between Polymorphisms in the DNA Repair Genes, XRCC1, APE1, and XPD and Acute Side Effects of Radiotherapy in Breast Cancer Patients Clin. Cancer Res., July 1, 2005; 11(13): 4802 - 4809. [Abstract] [Full Text] [PDF]
|
|